Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FFQPT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,612
Award facts
- Contract value 100% obligated
- $24,612.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $24,612.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents one of numerous orders placed against DMS Pharmaceutical Group's broader Indefinite Delivery Contract. The award carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will deliver pharmaceutical products and medical consumables to support Department of Defense healthcare operations, drawing from its extensive portfolio of branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical supplies.
This delivery order is executed under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy through which the Defense Logistics Agency establishes regional prime vendor contractors to supply recurring pharmaceutical needs to military healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under this program (contract SPE2DR) with a ceiling value of $499,999,999 and a completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. The contractor's established performance across diverse product categories and therapeutic areas, including oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals, positions it as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DX26FFQPT?
SPE2DX26FFQPT was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 3, 2025.
How much is contract SPE2DX26FFQPT worth?
The government has obligated $24,612 on SPE2DX26FFQPT.
Is contract SPE2DX26FFQPT an order under another contract?
Yes. SPE2DX26FFQPT is a delivery order under SPE2DX17D9419, an indefinite delivery contract.
Was contract SPE2DX26FFQPT competed?
The extent of competition for SPE2DX26FFQPT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award